Marathon runners and heart patients put a new troponin test to the ultimate challenge
NCT ID NCT07726420
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This study tests whether a lab technique called polyethylene glycol (PEG) precipitation can tell the difference between a true heart attack and a harmless condition called macrotroponin, where troponin molecules clump together and falsely signal heart damage. Researchers will compare results from 160 participants: people hospitalized with acute coronary syndrome and healthy marathon runners before and after a race. The goal is to establish clear cut-off values for the test, potentially preventing unnecessary heart procedures in people who are actually healthy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a diagnostic test using polyethylene glycol (PEG) precipitation to distinguish macrotroponin from true troponin elevation
- What this could lead to
- If successful, this could give doctors a quick, reliable way to avoid false heart-attack alarms and unnecessary procedures.
- What could go wrong
- This is an early diagnostic study, not a treatment trial. The test may not prove accurate enough for routine use, and cut-off values remain unestablished.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Technical University Munich
RECRUITINGMunich, Bavaria, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Bedside flu shot for heart patients: a simple strategy to save lives?
- Could a Two-Drug combo stop repeat heart attacks?
- Ear zaps during heart attack may shield the heart from damage
- Could a sleep apnea machine keep heart patients out of the hospital?
- Heart attack aftermath: new imaging method may spot hidden danger zones better than standard tests
- Heart healing from the inside out: resilience training may boost recovery after cardiac events